Unconfigured Ad
Collapse
Any topic/question that does not fit into the subcategories below. If you're unsure of where to put something, ask in here!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by nilshomer, 05-08-2010, 02:19 PM
|
52 responses
118,315 views
0 reactions
|
Last Post
by archana87
04-23-2019, 01:18 PM
|
||
|
Started by njt638, 08-21-2011, 04:03 AM
|
1 response
1,672 views
0 reactions
|
Last Post
by samanta
08-24-2011, 11:56 AM
|
||
|
Started by ardmore, 07-18-2011, 06:50 AM
|
12 responses
3,514 views
0 reactions
|
Last Post
by ardmore
08-24-2011, 09:10 AM
|
||
|
Started by yhong, 08-22-2011, 04:57 PM
|
1 response
2,204 views
0 reactions
|
Last Post
by nilshomer
08-24-2011, 09:10 AM
|
||
|
Started by ijivanjee, 08-19-2011, 05:09 AM
|
2 responses
2,195 views
0 reactions
|
Last Post
by ijivanjee
08-24-2011, 05:42 AM
|
||
|
Started by attilav, 08-18-2011, 04:07 AM
|
2 responses
2,610 views
0 reactions
|
Last Post
by scordes
08-22-2011, 12:59 PM
|
||
|
Started by whitestein, 08-17-2011, 08:22 AM
|
2 responses
2,596 views
0 reactions
|
Last Post
by whitestein
08-19-2011, 05:36 AM
|
||
|
Started by schmima, 08-18-2011, 02:30 AM
|
2 responses
3,590 views
0 reactions
|
Last Post
by schmima
08-18-2011, 04:03 AM
|
||
|
Started by bbrij87, 08-03-2011, 01:45 PM
|
11 responses
5,962 views
0 reactions
|
Last Post
by Bioderek
08-18-2011, 02:23 AM
|
||
|
Started by joscarhuguet, 08-17-2011, 11:11 AM
|
0 responses
3,069 views
0 reactions
|
Last Post
by joscarhuguet
08-17-2011, 11:11 AM
|
||
|
Started by marcowanger, 08-14-2011, 06:13 PM
|
0 responses
6,935 views
0 reactions
|
Last Post
by marcowanger
08-14-2011, 06:13 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:22 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:22 AM
|
||
|
Started by SEQadmin2, 09-02-2026, 12:32 PM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
09-02-2026, 12:32 PM
|
||
|
Started by SEQadmin2, 08-24-2026, 10:32 AM
|
0 responses
50 views
0 reactions
|
Last Post
by SEQadmin2
08-24-2026, 10:32 AM
|